Nextech Invest, Ltd.

CIK

1595430

Location

Zurich, V8

Portfolio Value

Mid $1,421,052,371

Diversification

Highly concentrated

Filing Date

Global Rank

#1,449 / 8,605 ▲ 337 · as of Mar 2026

Top Industry

Biotechnology 100.0%

3Y Alpha vs SPY

+242.3%

Period ended 3 months ago

Filed May 15, 2026 · 55d

5 quarters · since Mar 2025

Clone Performance

May 2025–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio

+341.8%

SPY

+28.1%

Annualised alpha

+240.0%

Max drawdown

−13.1%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

17 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

52.0%

−7.3 pts

Top 5

85.5%

−0.2 pts

Top 10

95.8%

−0.7 pts

HHI

3,040

Highly concentrated−706

Portfolio Trend

5 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$1,421,052,371	17

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

4 positions

Ticker	Company	Δ Shares	Shares	Value
RLAY	Relay Therapeutics, Inc.	+825,000	5,526,506	$54,988,734
ALMS	Alumis Inc.	+625,000	3,540,998	$78,008,185
ENGN	enGene Therapeutics Inc.	+200,000	2,324,943	$15,832,861
GLUE	Monte Rosa Therapeutics, Inc.	+25,000	304,237	$5,004,698
No positions match the current search.

Trimmed

Positions the filer reduced

1 positions

Ticker	Company	Δ Shares	Shares	Value	Open
SPRY	ARS Pharmaceuticals, Inc.	−50,000	610,703	$4,903,945
No positions match the current search.

New Positions

Positions the filer opened this quarter

2 positions

Ticker	Company	Shares	Value
CTMX	CytomX Therapeutics, Inc.	4,449,932	$20,914,680
CRVS	Corvus Pharmaceuticals, Inc.	450,000	$6,583,500
No positions match the current search.

Sold Out

Positions the filer fully exited

No qualifying positions this quarter.

Portfolio Positions

Compact Export CSV View 13F filing

17 positions · $1,421,052,371 total · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
RVMD	Revolution Medicines, Inc. Healthcare	Held	7,601,087	0	$739,205,710	+22.1%	52.02%
TYRA	Tyra Biosciences, Inc. Healthcare	Held	4,055,861	0	$155,339,476	+45.7%	10.93%
TNGX	Tango Therapeutics, Inc. Healthcare	Held	7,266,081	0	$152,006,414	+136.1%	10.70%
ORIC	Oric Pharmaceuticals, Inc. Healthcare	Held	7,162,637	0	$90,750,610	+54.9%	6.39%
ALMS	Alumis Inc. Healthcare	Added	3,540,998	+625,000	$78,008,185	+174.1%	5.49%
RLAY	Relay Therapeutics, Inc. Healthcare	Added	5,526,506	+825,000	$54,988,734	+38.3%	3.87%
ZYME	Zymeworks Inc. Healthcare	Held	1,113,946	0	$27,893,207	−4.9%	1.96%
KYMR	Kymera Therapeutics, Inc. Healthcare	Held	278,896	0	$23,229,247	+7.0%	1.63%
CTMX	CytomX Therapeutics, Inc. Healthcare	NEW	4,449,932	NEW	$20,914,680	NEW	1.47%
CNTX	Context Therapeutics Inc. Healthcare	Held	7,419,355	0	$19,438,710	+78.2%	1.37%
CGEM	Cullinan Therapeutics, Inc. Healthcare	Held	1,141,145	0	$16,215,670	+37.3%	1.14%
ENGN	enGene Therapeutics Inc. Healthcare	Added	2,324,943	+200,000	$15,832,861	−17.5%	1.11%
CRVS	Corvus Pharmaceuticals, Inc. Healthcare	NEW	450,000	NEW	$6,583,500	NEW	0.46%
ARVN	Arvinas, Inc. Healthcare	Held	539,394	0	$5,717,576	−10.6%	0.40%
SLN	Silence Therapeutics plc Healthcare	Held	952,400	0	$5,019,148	−13.3%	0.35%
GLUE	Monte Rosa Therapeutics, Inc. Healthcare	Added	304,237	+25,000	$5,004,698	+14.3%	0.35%
SPRY	ARS Pharmaceuticals, Inc. Healthcare	Reduced	610,703	-50,000	$4,903,945	−36.3%	0.35%